Fresenius Medical Care (FMS) Stock: Buy, Sell, or Hold?
FMS - Fresenius Medical Care AG
$22.26
-0.12 (-0.54%)
▼
5d:
-0.4%
30d:
-2.11%
90d:
-5.4%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Get Alerted When FMS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: FMS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: FMS shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.16
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.45
0.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FMS is currently trading at $22.26, which is considered oversold relative to its 30-day fair value range of $22.29 to $23.14. From a valuation perspective, the stock is trading at a premium (Forward PE: 8.4) compared to its historical average (7.0). At these levels, the market is pricing in 6.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, FMS is showing sideways momentum. The price is currently testing key support at $21.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FMS is showing sideways momentum. The price is currently testing key support at $21.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$22.29 -
$23.14
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($23.62)
- NEUTRAL: Trading at premium valuation - market expects 6.0% growth which is achievable
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$22.29 -
$23.14
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$21.98
Resistance Level
$23.08
Current Trend
Sideways
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.39
Wall Street Target
$23.62
(+6.1%)
Revenue Growth (YoY)
1.4%
Earnings Growth (YoY)
5.5%
Profit Margin
4.8%
Valuation Premium vs History
+6.0% premium
PE vs Historical
8.4 vs 7.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.0%
(market-implied from PE analysis)
1-Year Target
$23.60
(+6%)
2-Year Target
$25.01
(+12%)
3-Year Target
$26.51
(+19%)
3-Yr Target (if PE normalizes)
(PE: 8→7)
PE COMPRESSION
$22.12
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 28.3%)
$114.35
(+414%)
Base:
(SPY PE: 8.4, Growth: 28.3%)
$47.04
(+111%)
Bear:
(PE: 7.0, Growth: 28.3%)
$39.24
(+76%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 11.78 | Current EPS (TTM): $1.90
Bull Case
$34.37
(+54%)
Analyst growth 39.6%, PE expands to 13.0
Base Case
$31.25
(+40%)
Market implied 39.6%, PE stable at 11.8
Bear Case
$15.22
(-32%)
Severe decline -20.0%, PE contracts to 10.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 02, 2026 2:40 AM ET
Data refreshes hourly during market hours. Next update: 3:40 AM
Data refreshes hourly during market hours. Next update: 3:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FMS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 58 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$454 | 46 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 45 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$134 | 53 HOLD |
